Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro

30 Mar 20264 min read0 viewsINTERVENTIONAL Trial

GIST

RECRUITING · INTERVENTIONAL · TREATMENT study · Sexually Transmitted Diseases · Enrollment 200 · Sponsor: Oswaldo Cruz Foundation

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Infectious Disease on 30 Mar 2026. The item focuses on Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

DOI

NCT07500415

Open Original Source More Feed Items

Related by Condition/Drug

Front ImmunolRelated by Conditionhiv

Immunological research landscapes and emerging immune mechanisms in HIV/HBV co-infection: a bibliometric analysis (2014–2024)

Infectious Disease • 14 May 2026

Front ImmunolRelated by Conditionhiv

Clinical characteristics and long-term prognosis of talaromycosis in children with novel and reported inborn errors of immunity

Infectious Disease • 13 May 2026

WHORelated by Conditionhiv

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Infectious Disease • 09 Mar 2026

Feed Metadata

Source

ClinicalTrials.gov